Medpace Holdings, Inc. - Common Stock (MEDP)

Historical Holders from Q3 2016 to Q3 2025

Symbol: MEDP on Nasdaq
Type / Class: Equity / Common Stock
Shares outstanding: 28,414,670
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 23,961,178
Holdings value: $12,311,524,811
% of all portfolios: 0.02%
Number of holders: 661
Number of buys: 314
Number of sells: -330
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Troendle August J.	20%	+2.5%	$3,389,756,472	-$200,043,884	5,682,934	-5.6%	August J. Troendle	26 Nov 2025

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	23,961,178	$12,311,524,811	-$1,139,217,026	$91,197,244	$53,230,796	$514.16	661
2025 Q2	26,383,560	$8,288,435,409	+$333,924,731	$30,754,476	$17,005,823	$313.86	594
2025 Q1	25,351,494	$7,718,802,423	-$9,540,540	$21,674,197	$14,151,422	$304.69	578
2024 Q4	25,340,363	$8,420,105,198	+$2,781,687	$23,058,094	$24,687,020	$332.23	584
2024 Q3	25,315,006	$8,458,156,137	-$55,147,913	$69,088,811	$14,278,616	$333.8	577
2024 Q2	25,134,495	$10,351,346,830	-$31,621,959	$32,680,298	$15,938,595	$411.85	617
2024 Q1	25,247,742	$10,201,457,017	+$309,719,146	$47,325,965	$62,117,855	$404.15	585
2023 Q4	24,605,167	$7,542,681,992	+$229,825,667	$11,065,733	$16,552,620	$306.53	537
2023 Q3	23,978,527	$5,807,458,403	-$1,302,082	$12,324,417	$15,520,533	$242.13	482
2023 Q2	23,852,532	$5,728,812,297	-$189,263,357	$6,028,267	$20,102,229	$240.17	457
2023 Q1	24,865,090	$4,674,846,132	+$108,498,439	$6,957,850	$3,685,780	$188.05	412
2022 Q4	24,347,700	$5,172,004,976	-$300,121,456	$10,831,644	$8,878,785	$212.41	415
2022 Q3	25,865,491	$4,065,022,806	-$87,591,355	$6,601,000	$19,599,000	$157.17	341
2022 Q2	26,319,125	$3,938,916,557	-$138,934,775	$6,480,000	$13,679,000	$149.67	328
2022 Q1	27,353,541	$4,474,335,613	-$288,675,997	$7,591,000	$18,650,000	$163.59	336
2021 Q4	28,637,675	$6,230,873,750	-$17,998,983	$3,333,000	$11,889,000	$217.64	378
2021 Q3	28,619,666	$5,416,650,219	+$197,797,063	$9,840,000	$24,509,000	$189.28	330
2021 Q2	27,593,763	$4,873,907,764	-$68,366,795	$8,885,000	$14,942,000	$176.63	319
2021 Q1	27,985,360	$4,594,004,259	+$104,275,194	$1,591,000	$9,564,000	$164.05	312
2020 Q4	27,673,447	$3,850,051,602	+$93,810,402	$7,875,000	$7,600,000	$139.2	307
2020 Q3	27,120,457	$3,030,671,185	-$135,168,695	$1,397,000	$4,402,000	$111.75	304
2020 Q2	28,380,989	$2,639,244,485	+$14,303,231	$3,646,000	$3,711,000	$93.02	267
2020 Q1	28,430,389	$2,087,064,779	-$34,301,689	$3,308,000	$4,992,000	$73.38	262
2019 Q4	28,848,283	$2,419,068,792	+$10,252,483	$5,274,000	$3,901,000	$84.06	245
2019 Q3	28,714,636	$2,408,420,205	-$89,388,643	$6,614,000	$7,842,000	$84.04	261
2019 Q2	29,995,588	$1,944,530,366	+$211,380,396	$7,870,000	$3,571,000	$65.42	218
2019 Q1	27,512,201	$1,621,089,764	-$96,482,454	$9,017,000	$9,273,000	$58.97	227
2018 Q4	29,281,202	$1,538,952,893	+$254,103,472	$2,671,000	$4,539,000	$52.93	214
2018 Q3	24,153,990	$1,447,749,021	+$617,515,363	$3,738,000	$5,488,000	$59.91	207
2018 Q2	13,950,730	$599,818,408	+$188,465,083	$0	$1,428,000	$43	143
2018 Q1	9,597,152	$335,058,130	+$32,462,085	$237,000	$1,578,000	$34.91	110
2017 Q4	8,576,307	$311,077,359	+$80,900,389			$36.26	114
2017 Q3	6,398,882	$204,099,830	+$6,836,884			$31.9	86
2017 Q2	6,311,396	$183,034,029	-$10,975,727			$29	79
2017 Q1	6,619,292	$197,596,759	-$7,556,903			$29.85	77
2016 Q4	7,258,548	$261,798,100	+$44,435,837			$36.07	79
2016 Q3	6,172,151	$184,306,689	+$184,306,689			$29.86	68